Exoskeleton Companies

The exoskeleton market is estimated to be USD 0.56 billion in 2025 and is projected to reach USD 2.03 billion by 2030, registering a CAGR of 29.4% during the forecast period. Recent key developments, such as the FDA's clearance of medical exoskeletons, are enhancing confidence among healthcare providers and promoting their clinical adoption. Increased investments in research and development, along with collaborations between technology companies and healthcare institutions, are driving innovation in this field. Additionally, advancements in battery technologies and material science are making exoskeletons more practical and accessible, further supporting widespread adoption and market growth.

Some of the major players in the exoskeleton market with significant global presence include Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB (South Korea), B-Temia (Canada), and Rex Bionics Ltd. (New Zealand). These companies offer various exoskeletons tailored to diverse industries, including healthcare, defense, construction, and others. New product launches, collaborations, expansions, and acquisitions are key strategies adopted by players to enhance their product portfolios, increase their market share, and expand their presence. In addition, many of these players are focusing on integrating advanced technologies such as AI-integrated robotic systems and ergonomic designs to enhance product performance and user safety.

To know about the assumptions considered for the study download the pdf brochure

Major Exoskeleton Companies Include:

• Ekso Bionics (US)
• Ottobock (Germany)
• DIH Medical (Switzerland)
• Comau (Italy)
• Myomo Inc. (US)
• CYBERDYNE Inc. (Japan)
• Lifeward Ltd. (Israel)
• Hyundai Motor Group Robotics LAB (South Korea)
• B-Temia (Canada)
• Rex Bionics Ltd. (New Zealand)
• ABLE Human Motion (Spain)
• Laevo Exoskeletons (Netherlands)
• German Bionic Systems GmbH (Germany)
• Levitate Technologies, Inc. (US)

In January 2024, Ekso Bionics launched GaitCoach, its next-generation gait therapy software for EksoNR. Designed to enhance rehabilitation, GaitCoach provides real-time feedback, personalized guidance, and intuitive user experience, simplifying robotic therapy for both patients and clinicians.

In June 2023, Hyundai Motor Group Robotics LAB developed the X-ble MEX, a medical wearable robot designed to assist with lower limb rehabilitation and joint mobility. This innovative device will be used in rehabilitation programs for patients with mobility impairments at Seoul Asan Hospital and the National Rehabilitation Centre.

Ekso Bionics is a leading company in wearable robotics, specializing in exoskeleton technology to improve human strength, mobility, and endurance. It operates through two segments: EksoHealth and EksoWorks. The EksoHealth segment offers medical exoskeletons like EksoNR for rehabilitation, Ekso Indego Therapy for stroke and spinal cord injury, and Ekso Indego Personal for home use, along with EksoPulse analytics and EksoCare services. The EksoWorks segment provides the EVO exoskeleton for industrial use and is developing the Ekso Nomad for launch in 2025. Ekso Bionics serves clients globally across the Americas, EMEA, and APAC regions.

Ottobock is a med-tech company focused on biomechanical and orthopedic solutions, offering advanced prosthetics, orthotics, and exoskeleton technologies to enhance mobility and workplace ergonomics. It operates across segments, including prosthetics, orthotics, mobility solutions, and industrial exoskeletons. Exoskeletons are offered under the industrial exoskeletons segment, with products like IX BACK AIR, IX BACK, and IX SHOULDER AIR designed to reduce physical strain and prevent musculoskeletal issues. Other key innovations include the C-Leg knee joint, C-Brace orthosis, and bebionic hand. Ottobock has a global footprint in over 35 countries, serving markets across Europe, North America, Asia, Africa, and Australia.

DIH Medical is a global provider of advanced rehabilitation therapy solutions, integrating robotic and virtual reality (VR) technologies to enhance human movement and therapeutic outcomes. The company operates across key segments, including robotic rehabilitation, VR therapy, and connected care. Exoskeleton-based rehabilitation solutions are offered under its Hocoma brand, featuring products like ErigoPro, Lokomat, Andago V2.0, and the Armeo series for gait, balance, and upper limb therapy. Additional offerings include HocoNet for data-driven care and SafeGait for safety-in-balance training. DIH serves markets across APAC, EMEA, and North America through a hub-and-spoke model tailored to regional healthcare needs.

Comau is a global leader in industrial automation, offering sustainable and Industry 4.0-enabled solutions to improve efficiency and productivity across various sectors. The company operates across segments such as robotics, digital platforms, and automation technologies. Its wearable robotics and exoskeletons, offered under the MATE product family, are designed to reduce physical strain, enhance ergonomics, and support lumbar and shoulder muscles during industrial tasks. Comau’s broader portfolio includes industrial robots, vision systems, robotic software, and IoT platforms. With 7 innovation centers and 12 plants in 12 countries, Comau maintains a strong global presence and localized support network.

Myomo Inc. is a medical robotics company specializing in wearable technology to assist individuals with neuromuscular disorders in regaining upper limb mobility. It operates in a single business segment focused on Myoelectric Orthotics, with its primary product being the MyoPro—a robotic arm brace that detects weak muscle signals to enable arm and hand movement. The MyoPro is designed for use in rehabilitation and at home, offering non-surgical support for patients with stroke, spinal cord injuries, or neurological conditions. Myomo serves the US market and is expanding internationally through partnerships in Europe and Asia.

Market Ranking

The exoskeleton market is growing at a significant rate, with leading major players such as Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), and Myomo Inc. (US) actively contributing to its growth. Among the leading players, Ottobock and Ekso Bionics are prominent in the medical and rehabilitation segments, while Comau focuses on industrial exoskeletons for workforce support. DIH Medical is strengthening its position through strategic partnerships and acquisitions. Myomo Inc. has seen growth in upper-limb exoskeletons and holds a competitive position in the North American market, though its scale is smaller compared to global leaders.

Related Reports:

Exoskeleton Market by Component (Sensors, Actuators, Power Systems, Controllers, Software), Functionality (Assistive, Rehabilitative, Augmentative, Preventive), Type (Powered, Passive, Hybrid), Body Part (Lower, Upper, Full Body) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com